Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Challenges of hypertension and dementia in the Indian subcontinent: a review

Journal of Human Hypertension volume 33, pages 568–574 (2019)Cite this article

Subjects

Abstract

Hypertension is regarded as a major contributor to vascular disease. Vascular disease is a fairly common denominator in a large percentage of cases of dementia. Despite this strong connecting link, dementia is often not considered as a mainstream problem consequent to hypertension, though there is an alarming increase in the number of cases of dementia. While established dementia has very few treatment options, prevention of development and slowing of progression of dementia by proper treatment of hypertension could be an important strategy, especially so, in a financially challenged Indian subcontinent with inhomogeneous health coverage.

None of us wants to be reminded that dementia is random, relentless, and frighteningly common—Laurie Graham

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Llibre Rodriguez J, Ferri CP, Acosta D. Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet. 2008;372:464–74.

    Article  Google Scholar 

  2. Gupta R, Xavier D. Hypertension: the most important non-communicable disease risk factor in India. Indian Heart J. 2018. https://doi.org/10.1016/j.ihj.2018.02.003.

    Article  Google Scholar 

  3. Elias MF, Goodell AL, Dore GA. Hypertension and cognitive functioning: a perspective in historical context. Hypertension. 2012;60:260–8.

    Article  CAS  Google Scholar 

  4. Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62:810–7.

    Article  CAS  Google Scholar 

  5. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3:186–91.

    Article  Google Scholar 

  6. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, et al. Dementia after stroke: the Framingham Study. Stroke. 2004;35:1264–8.

    Article  Google Scholar 

  7. Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006;368:387–403.

    Article  CAS  Google Scholar 

  8. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology. 2009;72:368–74.

    Article  Google Scholar 

  9. Rajkumar S, Kumar S, Thara R. Prevalence of dementia in a rural setting: a report from India. Int J Geriatr Psychiatry. 1997;12:702–7.

    Article  CAS  Google Scholar 

  10. Vas CJ, Pinto C, Panikker D. Prevalence of dementia in an urban Indian population. Int Psychogeriatr. 2001;13:439–50.

    Article  CAS  Google Scholar 

  11. Nagai M, Hoshide S, Kazuomi K. Hypertension and dementia. Am J Hypertens. 2010;23:116–24.

    Article  Google Scholar 

  12. Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ. 2001;322:1447–51.

    Article  CAS  Google Scholar 

  13. Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, et al. Apolipoprotein E epsilon 4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002;137:149–55.

    Article  CAS  Google Scholar 

  14. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology. 2002;58:1175–81.

    Article  CAS  Google Scholar 

  15. Tzourio C, Laurent S, Debette S. Is hypertension associated with an accelerated aging of the brain? Hypertension. 2014;63:894–903.

    Article  CAS  Google Scholar 

  16. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment. Lancet. 2006;367:1262–70.

    Article  Google Scholar 

  17. Das SK, Bose P, Biswas A, Dutt A, Banerjee TK, Hazra AM, et al. An epidemiologic study of mild cognitive impairment in Kolkata, India. Neurology. 2007;68:2019–26.

    Article  CAS  Google Scholar 

  18. The SPRINT MIND Investigators for the SPRINT Research Group. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321:553–61. https://doi.org/10.1001/jama.2018.21442

    Article  PubMed Central  Google Scholar 

  19. Gupta R, Gupta VP, Prakash H, Agrawal A, Sharma KK, Deedwania PC. 25 year trend in hypertension prevalence, awareness, treatment and control in an Indian urban population—Jaipur Heart watch. Indian Heart J. 2018;70:802–7.

    Article  Google Scholar 

  20. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.

    Article  CAS  Google Scholar 

  21. O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet. 1988;2:397.

    Article  Google Scholar 

  22. Li Y, Staessen JA, Lu L, Li LH, Wang GL, Wang JG. Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study. Hypertension. 2007;50:333–9.

    Article  CAS  Google Scholar 

  23. Wijkman M, Länne T, Engvall J, Lindström T, Ostgren CJ, Nystrom FH. Masked nocturnal hypertension—a novel marker of risk in type 2 diabetes. Diabetologia. 2009;52:1258–64.

    Article  CAS  Google Scholar 

  24. Syrseloudis D, Tsioufis C, Andrikou I, Mazaraki A, Thomopoulos C, Mihas C, et al. Association of night- time hypertension with central arterial stiffness and urinary albumin excretion in dipper hypertensive subjects. Hypertens Res. 2011;34:120–5.

    Article  Google Scholar 

  25. Perez-Lloret S, Toblli JE, Cardinali DP, Malateste JC, Milei J. Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping. Int J Cardiol. 2008;127:387–9.

    Article  Google Scholar 

  26. Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036–45.

    Article  CAS  Google Scholar 

  27. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE) a case controlled study. Lancet. 2016;388:761–5.

    Article  Google Scholar 

  28. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council’s trial of hypertension in older adults. BMJ. 1996;312:801–5.

    Article  CAS  Google Scholar 

  29. Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, et al. Impact of the treatment of isolated systolic hypertension on behavioural variables. Results from the systolic hypertension in the elderly program. Arch Intern Med. 1994;154:2154–60.

    Article  CAS  Google Scholar 

  30. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, et al. HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET- COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7:683–9.

    Article  CAS  Google Scholar 

  31. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, et al. Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002;162:2046–52.

    Article  Google Scholar 

  32. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069–75.

    Article  CAS  Google Scholar 

  33. Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, et al. HOPE Investigators. Heart outcomes prevention evaluation. Use of ramipril in preventing stroke: double blind randomised trial. BMJ. 2002;324:699–702.

    Article  CAS  Google Scholar 

  34. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21:875–86.

    Article  CAS  Google Scholar 

  35. Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008;7:875–84.

    Article  CAS  Google Scholar 

  36. McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;2:CD004034.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, PRS Hospital, Trivandrum, Kerala, 695002, India

    Tiny Nair

Authors
  1. Tiny Nair
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tiny Nair.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nair, T. Challenges of hypertension and dementia in the Indian subcontinent: a review. J Hum Hypertens 33, 568–574 (2019). https://doi.org/10.1038/s41371-019-0205-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-019-0205-z

This article is cited by

Search

Advanced search

Quick links